Skip to main content
The Journal of Biological Chemistry logoLink to The Journal of Biological Chemistry
. 2025 May 28;301(7):110307. doi: 10.1016/j.jbc.2025.110307

Efficient cell-free translation from diverse human cell types

Jana Ziegelmüller 1, Nikolaos Kouvelas 1,2, Nino Schwaller 1, Priyanka Thambythurai 1, Alexander M Hofer 1,2, Oliver Mühlemann 1,, Evangelos D Karousis 1,3,
PMCID: PMC12226075  PMID: 40447189

Abstract

Cell-free translation systems are indispensable for studying protein synthesis, enabling researchers to explore translational regulation across different cell types. The difficulties in producing cell-free translation systems from different cell types limit the ability to study regulatory mechanisms that depend on different biological contexts. Here, we present a scalable method for preparing translation-competent lysates from a range of frequently used human cell lines using dual centrifugation. We optimized lysis conditions for adherent and suspension cells, producing high-quality lysates from HEK-293 (adherent and in suspension), HeLa, SH-SY5Y, and U2OS cells. Our results demonstrate that cell-specific factors influence translation efficiency, with adherent HeLa cells showing the highest activity. We also observed that sensitivity to lysis conditions varies between cell lines, underscoring the importance of fine-tuning parameters for efficient protein production. Our method provides a robust and adaptable approach for generating cell-type-specific lysates, broadening the application of in vitro translation systems in studying translational mechanisms.

Keywords: cell-free translation, cell-type-specific lysates, dual centrifugation, in vitro translation, protein synthesis, synthetic biology, translational regulation


Cell-free biology describes the recapitulation, study, and exploitation of complex biological processes without intact cells (1) and has facilitated major advances in diverse research fields by enabling detailed mechanistic explorations and overcoming limitations owing to the complexity of intact cells. In the past, cell-free or in vitro translation has contributed to key discoveries, such as the elucidation of the genetic code (2). Recent improvements in cell-free translation systems have expanded their capabilities and potential applications in synthetic biology, biotechnology, and biomedicine. Some recent examples include findings in the features of aminoacyl tRNA synthetases and tRNAs (3), alternative ways to produce proteinosomes, particles that support cell-free transcription and translation (4), and the study of riboswitches (5). Cell-free expression systems have also been more systematically utilized to study the folding of membrane proteins, which are often challenging to express in living cells (6). Furthermore, constructing artificial cells based on cell-free systems (7), integrating cell-free expression reactions in artificial biomolecular condensates (8), and inhibiting translation in synthetic cells using membrane-less organelles (9) fuel the potential for future advances in synthetic biology.

In vitro translation systems based on cell lysates allow for the rapid and efficient synthesis of proteins in a cell-free environment, enabling researchers to study protein translation without needing intact cells. The Rabbit Reticulocyte Lysate (RRL) is a cell-free, lysate-based system derived from the immature red blood cells (reticulocytes) of rabbits that is widely used in molecular biology and biochemistry for in vitro protein synthesis (10). This system provides a rich source of the components necessary for translation, including ribosomes, tRNAs, amino acids, and various translation factors. However, RRL is of limited use for studying the mechanism of mammalian translation. The ability to translate mRNAs without a 7-methyl-G cap structure and cap-binding proteins and its non-canonical translation initiation activity at internal mRNA sites limit the physiological relevance of this system (11). High levels of globin mRNA and tissue-specific RNases can interfere with translation and degrade mRNAs, reducing both efficiency and yield (12, 13). Therefore, the specialized nature of reticulocytes may not accurately represent translation processes in other cell types. Additionally, RRL cannot be easily genetically manipulated to deplete or enrich specific protein factors (2). These factors can affect the specificity, control, and broader applicability of the RRL system in certain experimental contexts (2).

Given the limitations of RRL and the ethical issues associated with its production, there has been a growing interest in developing cell-free translation systems based on lysates from immortalized human cells. Such systems offer a more physiologically relevant environment, capturing tissue- and cell-type-specific factors critical for proper translation in mammalian systems. By preserving human regulatory elements, post-translational modifications, and translational control mechanisms, human cell-derived lysates provide a powerful tool for studying translation in a context resembling in vivo conditions. This has significant implications for fields such as synthetic biology, structural biology, and drug screening, where accurate recapitulation of human cellular processes is essential (2, 14).

Efficient cell-free translation systems have been produced from various mammalian cell lines and used to study the mechanism of translation and translation-relevant processes (15, 16, 17, 18). A common challenge of these protocols is the variability in translation efficiency depending on the lysis conditions, leading to significant batch-to-batch variation. To address these problems, we previously developed an in vitro translation system based on HeLa S3 suspension cells (19). The key innovation of our approach was to lyse the cells by dual centrifugation, a technique traditionally used in the chemical industry that provides efficient sample homogenization by applying well-controlled shearing forces. We established dual centrifugation as a robust method for routine cell lysis under various buffer conditions, yielding lysates capable of cap- and IRES-dependent translation. The efficacy of this new method is documented in studies exploring the role of Nsp1, a virulent factor from SARS-CoV-2, in human cells (20, 21, 22) and translation re-initiation (23).

Here, we report the production of translation-competent lysates from different commonly used human cell lines using our dual centrifugation approach. We used adherent HEK-293 cells to benchmark the production of translation-competent lysates from adherent cells, and we adapted the protocol to produce lysates for cell-free translation from adherent HeLa, U2OS, and SH-SY5Y cells, as well as from HEK FreeStyle 293 suspension cells, from here on referred to as HEK FreeStyle cells.

Results and discussion

Optimized conditions to yield translation-competent lysates from adherent HEK-293 cells

Previously, we streamlined the production of translation-competent lysates using HeLa S3 suspension cells by dual centrifugation (DC) and have successfully used it to study translation-related processes (19). Acknowledging the importance of examining molecular mechanisms across different cell types, we set out to test this method's ability to produce translation-competent lysate from HEK293 Flp-In T-Rex cells, from here on referred to as HEK FITR cells. For this purpose, we grew the cells to 80 to 90% confluency, harvested them by trypsinization, and resuspended them in a translation buffer supplemented with essential salts and an energy regeneration system consisting of creatine phosphate and creatine kinase, previously optimized for HeLa S3 in vitro translation (19). We then subjected the cell suspensions to a range of DC conditions, with speeds varying from 500 to 1′200 rpm for 1 to 4 min. The processed lysates, namely, the supernatant after spinning down the DC-lysed material, were used to translate a 3xFLAG-tagged Renilla luciferase (3xFLAG-RLuc) reporter mRNA for 1 hour at 37 °C, followed by luminescence measurements (Fig. 1A). Although we obtained translation-competent lysates from almost all conditions, translation efficiency depended on both the duration and the intensity of DC treatment, with highest RLuc signals observed at 800 and 900 rpm for 1 min. These conditions differ from the DC conditions for HeLa S3 lysate, which yield best translation activity at 500 rpm for 4 min (19), suggesting that different cell types require different lysis conditions to achieve optimal translation efficiency of the derived lysates. To monitor the cell lysis efficiency under the different DC conditions, we performed Trypan Blue staining, where living cells are visible as white spheres, whereas dead cells and nuclei as dark blue foci. As shown in Figure 1B, the lysis efficiency depends on the applied centrifugal forces. Similar to our experience with HeLa S3 cells, at the optimal condition (800–900 rpm for 1 min), approximately 50% of the cells were lysed with the cell nuclei remaining intact. DC at higher rpm or for longer periods leads to a higher proportion of lysed cells but concomitantly lower translation efficiency of the resulting lysates. This may result from damaging sensitive components essential for translation or disruption of cellular organelles such as the nucleus, which could release nuclear components that negatively impact translation.

Figure 1.

Figure 1

Preparation of translation-competent lysate from HEK FITR cells using DC. A, Comparison of luminescence output of HEK FITR lysates produced under different dual centrifugation (DC) conditions by Renilla luciferase assay. B, Examination of HEK FITR cell integrity after DC by Trypan Blue staining. C, Luciferase assay comparing in vitro translation efficiency of HEK FITR lysates prepared with or without 15% glycerol in the translation buffer. D, Comparison of translation efficiency between lysates from HEK FITR cells harvested by trypsinization or scraping. The cells were resuspended in a translation buffer containing 15% glycerol and lysed by DC (800 rpm, 1 min, −5 °C) after harvesting. E, Trypan Blue staining of HEK FITR cells harvested by trypsinization (top) or scraping (bottom). In (A, C and D) each dot depicts the value of an individual experiment for which the luminescence was measured three times. Mean and SD are shown. All translation reactions were performed using a lysate concentration of 1 x 105 cell equivalents/μl containing 5 fmol/μl 3xFLAG-RLuc mRNA, at 37 °C for 1 h in a total volume of 25 μl of which everything was used for the Renilla luciferase assay.

Attempting to further improve the translation efficiency of the HEK FITR lysate, we assessed the effect of glycerol on cell-free translation based on its molecular crowding effect (14). We observed an 80% increase in translation efficiency upon adding 15% glycerol to the translation buffer in which the cells are suspended and lysed (Fig. 1C). Notably, addition of glycerol did not increase the translation efficiency of HeLa S3 lysates, suggesting that these lysates may already translate with their maximal translation capacity (Fig. S1A). In contrast, HEK FITR lysates might be less concentrated and, therefore, benefit from increasing the local concentration of translation factors by adding a crowding agent.

To speed up the lysate preparation procedure, we further tested whether we could harvest the cells by scraping the plates instead of the more time-consuming trypsinization procedure. However, we observed that only lysates originating from trypsinized cells were translationally competent (Fig. 1D). Harvesting the cells by scraping is a harsh treatment that damages and lyses a large proportion of the HEK FITR cells, which was clearly visible when the cells were microscopically examined directly after harvesting, before DC (Fig. 1E). Since scraping can influence the integrity of cellular membranes (24), we speculate that the resulting release of inhibitory factors from membrane-bound compartments might be responsible for the reduced translational activity. Alternatively, the mechanical stress of scraping may inactivate critical elements of the translation machinery that are preserved when cells are trypsinized.

In summary, our optimal lysate preparation protocol for HEK FITR cells includes harvesting the cells by trypsinization and resuspension after washing in a translation buffer containing 15% glycerol and DC at 800 rpm for 1 min.

Characterization of HEK FITR translation-competent lysate

To characterize the HEK FITR lysate, we first tested the duration of its translation activity using the 3xFLAG-RLuc reporter mRNA. We found that protein production increases linearly for at least 1 hour of incubation at 37 °C (Fig. 2, A and B). Furthermore, we titrated the reporter mRNA concentration in the translation reaction and observed an increase in translation at a concentration range of 2.5 to 20 fmol of reporter mRNA per μl of cell-free translation reaction (Fig. 2C).

Figure 2.

Figure 2

Characterization of HEK FITR lysate. AB, Western blot analysis and Renilla luciferase assay of time-course in vitro translation reactions using the 3xFLAG-RLuc mRNA reporter. C, Renilla luciferase assays of in vitro translation reactions with varying 3xFLAG-RLuc reporter mRNA concentrations. DE, Western blot analysis of time-course in vitro translation reactions using 3xFLAG-HBB and SMG6-3xFLAG mRNAs, respectively. F, Renilla luciferase activity measurements of in vitro translation reactions of 3xFLAG-RLuc in HEK FITR lysates subjected to snap-freezing for 1x, 2x or 4x. G, Western blot analysis of in vitro translation reactions using a 3xFLAG-HBB reporter mRNA with or without a poly(A) tail. H, Renilla luciferase assay of in vitro translation reactions of the 5′ capped 3xFLAG-RLuc reporter in the presence of increasing levels of the free cap analogue m7G(5′)ppp(5′)G. I, Western blot analysis of in vitro translation reactions of a 3xFLAG-RLuc reporter mRNA in HEK FITR, HeLa S3 or rabbit reticulocyte lysate (RRL). Antibodies used for Western blot analysis are depicted at the bottom of the blots with vinculin serving as a loading control. All translation reactions were performed with 5 fmol RNA/μl and incubated for 1 h at the temperatures specified below. For (AH) a lysate concentration of 1 × 105 cell equivalents/μl was used and the reactions were incubated at 37 °C, except for H, for which the reactions were incubated at 33 °C. RRL translation reactions in (I) were performed according to the manufacturer’s instructions, using a lysate concentration of 70% and an incubation temperature of 30 °C. HeLa S3 and HEK FITR reactions for (I) were adjusted to a lysate concentration of 1.4 × 105 cell equivalents/μl and were incubated at 37 °C. For (B, C, F and H), translation reactions with a total volume of 12.5 μl were prepared and used for the luciferase analysis. Each dot depicts the value of an individual experiment for which the luminescence was measured three times. Mean and SD are shown. For (A, D, and E), 25 μl translation reactions were performed of which 2.8 μl were loaded on the gel. For (G) 80 μl translation reactions were prepared of which 4 μl were loaded on the gel and the rest was used for RNA isolation for subsequent RT-qPCR analysis (Fig. S2, A and B). For (I) 50 μl translation reactions were performed of which 2 μl were loaded on the gel and 25 μl and 12.5 μl were used for luciferase analysis for Figure S2, E and D, respectively. Translation was inhibited in control samples by adding 0.1 mM cycloheximide (CHX).

To assess the versatility of the HEK FITR lysate, we explored the translation of reporter mRNAs encoding proteins of different sizes, including human beta-globin (HBB) and SMG6, an endonuclease involved in nonsense-mediated mRNA decay (NMD) (25, 26). Western blot analysis revealed that consistent with our findings for 3xFLAG-RLuc (37 kDa), we detected distinct single bands for 3xFLAG-HBB (21 kDa) and SMG6-3xFLAG (163 kDa) (Fig. 2, A, D and E), demonstrating the HEK FITR lysate’s ability to translate efficiently diverse proteins up to a size of at least 160 kDa and probably beyond, comparable to our previous results with HeLa S3 lysates (19).

To evaluate the stability of the HEK FITR lysate, we tested its resistance to freeze-thaw cycles. As shown in Figure 2F, the translation output of HEK FITR lysate remains unchanged through at least four freezethaw cycles, providing significant storage and handling advantages over other lysates such as RRL, which is recommended to only be used for up to two freeze-thaw cycles (10).

We examined the dependence of our cell-free translation system on the presence of a 5′ cap and a poly(A) tail. Poly(A)-dependent translation was investigated by comparing the translation of a 3xFLAG-HBB reporter with and without a 50 nucleotide-long poly(A) tail by western blotting. While the poly(A)+ reporter yielded a steady increase of the encoded protein during the 60-min incubation, for the poly(A)- reporter, no protein could be detected (Fig. 2G). Reverse transcription followed by quantitative PCR (RT-qPCR) analysis of the above-mentioned translation reactions revealed that while the poly(A)+ reporter remained stable during the incubation in the HEK FITR lysate (Fig. S2A), the poly(A)- reporter was reduced to approximately 50% independently of translation (Fig. S2B). Thus, both the stability and the translation of reporter mRNAs in HEK FITR lysates strongly depends on the presence of a poly(A) tail.

To assess the cap dependence of the translation activity of the HEK FITR lysate, we compared translation efficiency in the presence or absence of a free cap analogue (m7GpppG) that inhibits the translation of capped mRNAs by sequestering the initiation factor 4E (eIF4E) (27). As shown in Figure 2H, we observed an approximately three-fold decrease in the translation of the 3xFLAG-RLuc reporter in the presence of the cap analogue, supporting the cap dependence of our cell-free translation reactions.

To compare the translation activity of our HeLa S3 and HEK FITR lysates to commercially available Rabbit Reticulocyte Lysate (RRL), we assessed by Western blotting the production of 3xFLAG-RLuc protein after 60 min of incubation of the reporter mRNA. Compared to RRL, HeLa S3 lysates exhibited about 70% translation efficiency and HEK FITR lysates approximately 30% (Figs. 2I and Fig.S2C). Additionally, we observed that RRL interfered with the Renilla luciferase (RLuc) assay, showing reduced luminescence signals compared to HeLa S3 and HEK FITR translation reactions (Fig. S2D). To investigate this phenomenon, we performed HeLa S3 or RRL translation reactions for 60 min, followed by the addition of RRL or HeLa S3 lysate which had not been used for translation before measuring the luminescence signal. The luciferase signal of HeLa S3 translation reactions was strongly reduced when mixed with RRL lysate. In contrast, the luciferase signal increased when HeLa S3 lysate was added to RRL translation reactions. This suggests that components within RRL inhibit the enzymatic activity of the Renilla luciferase (Fig. S2E). This result confirms that our lysates are suitable for luminescence assays, in contrast to RRL.

Production of translation-competent lysates from various cell types

Using translation-competent lysates from different cell types facilitates studying cell-specific differences in translation, revealing tissue-specific regulatory mechanisms and responses. To this end, we addressed to what extent our protocol can be adapted to produce translation-competent lysates from different cell lines. Having succeeded in producing translation-competent lysates from HeLa S3 suspension cells and adherent HEK FITR cells, we next attempted to produce lysates from HEK FreeStyle, a HEK 293-based suspension cell line, and from adherent HeLa cells. To expand the range of cell-type-specific translation-competent lysates, we complemented our panel with two additional commonly used cell lines, SH-SY5Y and U2OS cells, which are of neuroblastoma and osteosarcoma origin, respectively.

Our previous work on HeLa S3 cells and HEK FITR cells (Fig. 1) highlighted the importance of optimizing the cell lysis parameters to yield lysates with high translational activity.

Therefore, we tested different DC parameters for each cell line, beginning with the optimal conditions for HeLa S3 and HEK FITR cells (500 rpm for 4 min and 800 rpm for 1 min, respectively). We then increased or decreased the DC rpms and duration, based on the translation efficiency of the initial lysates, until we identified conditions that maximized translation of the 3xFLAG-RLuc reporter protein (Fig. 3). Furthermore, we monitored cell lysis efficiency by Trypan Blue staining of the cell suspension samples after DC treatment (Fig. S3).

Figure 3.

Figure 3

Production of translation-competent lysates from various cell lines. AD, Optimization of dual centrifugation (DC) conditions for lysate preparation from HEK FreeStyle, HeLa adherent, SH-SY5Y and U2OS cells, respectively. Translation efficiency was assessed by luciferase assay performed following in vitro translation of the 3xFLAG-RLuc reporter mRNA for 1 h at 37 °C. The DC conditions tested are indicated on the x-axis. EH, Renilla luciferase assays of time-course in vitro translation of the 3xFLAG-RLuc mRNA in lysates of the different cell lines. The lysates employed were prepared under the conditions that yielded the highest translation efficiency (see AD), with these optimal conditions noted at the top of each graph. I–L, Western blot analysis of translation reactions from (EH). The antibodies used are depicted below each blot, with vinculin serving as a loading control. In (A-H), each dot depicts the value of an individual experiment for which the luminescence was measured three times. Mean and SD are shown. For (AD) and (EL), 25 and 40 μl translation reactions were performed, respectively. For (AH) 25 μl of the translation reactions were used for luciferase assay. For (IL) 2.8 μl of the translation reactions were loaded on the gel. All translation reactions were performed with a lysate concentration of 1 x 105 cell equivalents/μl and 5 fmol 3xFLAG–RLuc mRNA/μl translation reaction. 0.1 mM cycloheximide (CHX) was used to inhibit translation in control samples.

Both the translation efficiency readout and the Trypan Blue staining (Fig. 3, AD and Fig. S3) showed that certain cell lines, such as HEK FreeStyle, are more sensitive to DC and minor alterations of the lysis parameters, while others, like adherent HeLa cells, resulted in similar degrees of lysis and translation efficiency over a wide range of DC conditions. Interestingly, U2OS cells displayed a notably high lysis efficiency at the optimal condition. The observed differences in cell sensitivity to lysis parameters may be attributed to the distinct structural characteristics of these cell types.

Next, we assessed how the duration of in vitro translation is associated with producing the 3xFLAG-RLuc reporter protein. For this purpose, we conducted time-course translation experiments in the lysates produced from the different cell lines under their above-determined optimal DC conditions. Translation efficiency was assessed based on 3xFLAG-RLuc using luminescence and Western Blot measurements. As shown in Figure 3, EL, we observed an increase in Renilla luciferase activity during the first hour of translation, which reached a plateau at 2 hours in all cases, apart from the U2OS-derived lysate, which translated for a longer time. Thus, the reporter protein output increased over a shorter time window for all the newly tested cell lines, except for U2OS, compared to HeLa S3 lysates. As reported previously (19), HeLa S3 lysates increased the reporter protein output for at least 2 h of translation (Fig. S1B).

Successful production of translation-competent lysates from diverse cell lines demonstrates the adaptability of the protocol, broadening its application for studying cell-type-specific translation mechanisms. The different sensitivity of different cell types to lysis conditions underscores the need to optimize cell lysis protocols based on the unique structural characteristics of each cell type. This variation may impact lysate quality and downstream applications, highlighting the importance of fine-tuning dual centrifugation parameters. The plateau in translation efficiency over time indicates possible limitations in translation machinery or substrate availability over time, which may vary across cell types, necessitating further investigation into rate-limiting factors. Based on our results, we suggest 800 RPM for 1 min as a starting point for optimization.

Having optimized the lysate preparation protocol for each cell line, we next compared the translation efficiency of the different cell type-specific lysates after in vitro translation for 1 hour. The translation efficiency, measured through 3xFLAG-RLuc reporter activity and Western Blot analysis, shows a marked difference between cell lines (Fig. 4, A and B). Notably, the adherent HeLa cell lysate exhibited the highest translation efficiency, while SH-SY5Y and U2OS lysates demonstrated considerably lower levels of translation. Both HEK 293 lysates, from adherent FITR and suspension FreeStyle cells, showed similar translation efficiencies. It is important to note that these results reflect only a snapshot of translation efficiency for the different lysates under this specific translation condition. Adjusting the translation parameters could yield different outcomes. For example, extending the translation duration from 1 hour to 2 hours would result in considerably higher translation efficiencies in both U2OS and HeLa S3 lysates (Figs. 3, H and L, Fig. S1B).

Figure 4.

Figure 4

Comparison of translation efficiency of lysates from different cell types. A, Renilla luciferase assay comparing the translation efficiency of the different lysates presented in this study. Each dot depicts the value of an individual experiment for which the luminescence was measured three times. Mean and SD are shown. B, Western blot analysis of the corresponding translation reactions from (A). The antibodies used are depicted below the blots, with vinculin serving as a loading control. For (A-B) in vitro translation reactions contained 5 fmol 3xFLAG-RLuc mRNA/μl and were performed at 37 °C for 1 h with a lysate concentration of 1 x 105 cell equivalents/μl in a total volume of 40 μl. 0.1 mM cycloheximide (CHX) was used to inhibit translation in control samples. 15 μl of the reactions were used for the Renilla luciferase assay, and 2.3 μl were loaded on the gel for Western blot analysis. C, Schematic depiction of the workflow for preparing translation-competent lysate from various cell types created with Biorender.com.

The variation in translation efficiency across cell lines could reflect the importance of cell-type-specific factors in regulating translation but might also indicate different degrees of cell lysis or reduced activity of translation factors in these cell types. Differences in ribosome recruitment efficiency and stress response mechanisms could explain the delayed onset of translation in HEK Freestyle and U2OS lysates, while variations in the availability of essential components (ribosomes, translation factors, GTP, etc) likely account for the differing duration of translation activity across lysates.

Overall, we adapted DC parameters, as illustrated in Figure 4C, to achieve efficient lysis and produce translation-competent lysates. This method demonstrates versatility across various cell types, allowing us to adapt the conditions for adherent and suspension cells. Notably, the scalability of this approach makes it suitable for diverse cell-type-specific translation studies ranging from small-scale functional studies to large-scale biochemical purification experiments.

The possibility of producing translation-competent lysates from specific cell lines is instrumental for several reasons. Many translation-relevant processes require tissue-specific factors, and some proteins only acquire post-translational modifications in specific cell-type-derived lysates and not in others. For instance, extracts from HeLa cells proved inefficient in producing an N-glycosylated form of human immunodeficiency virus type-1 envelope protein 120 (gp120), while the hybridoma extract was able to fully N-glycosylate gp120 (28).

The ability to generate lysates from various cell cultures creates new opportunities to produce lysates from genetically modified cells, allowing for controlled variations in factors of interest through knockdown, knockout, and overexpression experiments. The protein production output can be further increased by the addition of auxiliary proteins and other modifications of parameters that can increase the translation rate, as previously reported (19, 29).

The success of the DC-based cell lysis protocol across different cell lines highlights the versatility and adaptability of the method. We anticipate that our lysate preparation can be applied to virtually any cell line, facilitating studies of cell-type-specific translation mechanisms across a wide range of biological and disease contexts. This opens exciting possibilities for both basic research and industrial applications, enabling the production of cell-free translation systems tailored to specific cellular environments. The ability to scale this process and produce ample amounts of translation-competent lysates renders it a valuable tool for high-throughput applications and facilitates cross-cell-type comparisons of translational activities. Furthermore, it is well suited for isolating cell-type-specific translation complexes in sufficient amounts and purity for cryogenic electron microscopy studies.

Cell-free translation systems are instrumental in studying translational mechanisms and producing proteins of interest in various biological contexts. Our method expands the possibility of producing translation-competent lysates from specific cell types, providing systems that are promising for the investigation of co- and post-translational phenomena, such as cell-type specific translation phenotypes (30), post-translational modifications (28), and viral manipulation (31, 32), which can differ between cell types.

Limitations of the study

While the DC method for preparing translation-competent lysates has proven versatile across various cell lines, each new cell type requires careful optimization of the lysis conditions, which is determined mainly by the DC speed and time. Achieving the right balance between disruption of the cell membrane and preserving translation activity, particularly for more delicate or hard-to-lyse cells, is crucial for maximizing the yield of recombinant protein. Additionally, while the method works well for cultured cell lines, its scalability remains untested for more complex tissues, like primary cells or multicellular tissues. These tissues present additional structural complexity, which may impede lysate quality and translation efficiency. Another consideration is the preservation of post-translational modifications, which may not be fully maintained during lysate preparation, potentially affecting studies of cellular regulation. Furthermore, the method may have limitations when applied to studying organelle-specific translation processes, such as those occurring in mitochondria or at the endoplasmic reticulum, where localized translation events play key roles.

Experimental procedures

General cell culture growth conditions

HEK293 Flip-In T-Rex (HEK FITR), SH-SY5Y and U2OS cells were cultured in DMEM/F-12 (Gibco, Cat No. 32500–043) medium supplemented with 100 U/ml penicillin, 100 μg/ml streptomycin and 10% FCS (BioConcept, Cat No. 2–01F30-I) (termed DMEM+/+), at 37 °C and 5% CO2 in a humid atmosphere on 150 cm2 dishes to 80 to 90% confluency. HeLa S3 cells were grown in DMEM+/+ medium and were grown for two passages in 150 cm2 dishes after thawing before transferring to suspension culture flasks in a volume between 20 ml - 600 ml growing in a range of 0.1 × 106 − 1.2 × 106 cells/ml. HEK FreeStyle 293 cells were cultured in HyClone SFM4HEK293 medium (Cytiva, Cat No. SH30521.02) in volumes between 20 ml and 600 ml in a range of 0.3 × 106 – 2 × 106 cells/ml at 37 °C and 8% CO2 in a humid atmosphere. Suspension culture flasks were used for growing HeLa S3 and HEK FreeStyle 293 cells (Corning flasks Cat No. 431405, 431147, and 431255).

Translation-competent lysate preparation

To prepare HEK FITR, HeLa adherent, SH-SY5Y, and U2OS lysates, the cells were grown on 8 – 12 × 150 cm2 cell culture dishes to an 80 to 90% confluency. To harvest the cells, they were washed with 10 ml PBS, 2 ml trypsin/EDTA was added per plate, and the cells were incubated at 37 °C until they were fully detached. When using cell scraping for harvesting HEK FITR cells, the medium was removed, and the cells were scraped in 500 μl PBS. The cells of 4 to 6 dishes were collected in a total volume of 20 ml of DMEM+/+. This step was repeated to collect the cells remaining on the plates. The cells were counted with Trypan Blue staining to calculate the required volume of translation buffer, transferred to 50 ml tubes, and centrifuged at 500 g for 2 min at 4 °C. The medium was discarded, and all cells were transferred in one 50 ml falcon tube in a total of 30 ml ice-cold 1x PBS pH 7.4. The resuspension was performed gently to prevent premature lysis of the cells. The cells were centrifuged at 500 g for 2 min at 4 °C, and the supernatant was discarded. The washing step was repeated in 10 ml 1x PBS pH 7.4. Next, the cells were resuspended in ice-cold translation buffer (33.8 mM HEPES pH 7.3, 63 mM K-acetate pH 5.5, 0.68 mM MgCl2, 54 mM KCl, 13.5 mM creatine phosphate, 230 ng/ml creatine kinase, 1x protease inhibitor cocktail (Bimake, Cat No. B14002), 15% glycerol cocktail (Bimake, Cat No. B14002), 15% glycerol (unless otherwise stated)) to reach a concentration of 2 × 108 cells/ml and the suspension was transferred to 2 ml screw cap microtubes (Sarstedt, Cat No. 72693) in 400 μl aliquots per tube. Cell lysis was performed by dual centrifugation using the ZentriMix 280 R system (Hettich AG) at a temperature of −5 °C. Cell lysis efficiency was monitored by staining the samples in a 1:6 dilution before and after dual centrifugation with 0.2% Trypan Blue (Thermo Fisher Scientific, Cat No.EVS-050) and observed under a light microscope using EVE Cell counting slides (NanoEnTek, Cat No. EVS-050). The samples were centrifuged at 13′000 g for 10 min at 4 °C, and the supernatant (lysate) was collected, snap-frozen, and stored at −80 °C.

For the production of translation-competent lysate from HEK FreeStyle 293 cells, the cells were grown to a density of 1.8 to 2 × 106 cells/ml in a volume of 200 ml. The cells were counted, and the lysate was prepared as described above. During the washing steps of the cells in PBS, all cells were combined in one 50 ml Falcon tube.

HeLa S3 lysate was prepared as described (19) with the modification that the translation buffer (33.8 mM HEPES pH 7.3, 63 mM K-acetate pH 5.5, 0.68 mM MgCl2, 54 mM KCl, 13.5 mM creatine phosphate, 230 ng/ml creatine kinase, 1x protease inhibitor cocktail (Bimake, Cat No. B14002), 15% glycerol cocktail (Bimake, Cat No. B14002), utilized in this work was not supplemented with amino acids. The final pH after lysate addition is 6.7.

In vitro transcription and capping

Reporter mRNAs were encoded from plasmids with a pCRII backbone. The 3xFLAG-RLuc (humanized) and the 3xFLAG-HBB reporter both contain an AG initiator sequence for capping with the CleanCap reagent AG (TriLink Biotechnologies, Cat No. N-7113–5), the HBB 5′ UTR and a short 3′ UTR with a length of 20 bp and a BsmFI binding site downstream of the poly(A) sequence for linearization. The 3xFLAG-HBB reporter without a poly(A) contains an AG initiator sequence for capping with the CleanCap reagent AG, the HBB 5′ UTR, and ORF, followed by a ClaI restriction enzyme cleavage sequence 4 base pairs downstream of the termination codon, which was used for linearization before in vitro transcription. The SMG6-3xFLAG reporter plasmid is described in (19) and contains the SARS-CoV-2 Leader sequence as the 5′ UTR, a 221 bp long 3′ UTR, and a ClaI cleavage site downstream of the poly(A) sequence. In all reporters, the template-encoded poly(A) sequence is 50 nts long.

Before in vitro transcription, the plasmids were linearized using BsmFI (Cat No. R0572 L) for 3xFLAG-RLuc and 3xFLAG-HBB or ClaI (Cat No. R0197L) for SMG6-3xFLAG and the 3xFLAG-HBB reporter without a poly(A) in reactions containing 40 ng/μl DNA (4 μg in total) in 1x CutSmart buffer (NEB, Cat No. B7204S) for 2 h or overnight at 37 °C, respectively. The linearization was monitored by loading 500 ng of DNA on a 1% agarose gel. The linearized DNA was purified using the ChIP DNA Clean & Concentrator kit (ZYMO research, Cat No. D5205), and eluted in 10 μl elution buffer. In vitro transcription, using the linearized plasmid as a template (10 μl of elution), was performed in a reaction containing 1x OPTIZYME transcription buffer (Thermo Fisher Scientific, Cat No. BP81161), 1 mM of each NTP (Thermo Fisher Scientific, Cat No. R0481), 1 U/μl RNase inhibitor (Vazyme, Cat No. R301–03), 0.001 U/μl pyrophosphatase (Thermo Fisher Scientific, Cat No. EF0221) and 1.5 U/μl T7 polymerase (Thermo Fisher Scientific, Cat No. EP0111). For the 3xFLAG-RLuc and 3xFLAG-HBB reporters 0.8 mM CleanCap reagent AG (TriLink Biotechnologies, Cat No. N-7113–5) was included in the reaction. The transcription reaction was incubated at 37 °C 1 h. An additional 1.5 U/μl T7 polymerase was added, and the reaction was further incubated for 1 h at 37 °C. Subsequently, 0.15 U/μl Turbo DNase (Invitrogen, Cat No. AM2238) was added, and the reaction was incubated at 37 °C for 30 min to digest the plasmid DNA. The transcribed mRNA was isolated using the Monarch RNA Cleanup Kit (New England Biolabs, Cat No. T2040 L), eluted in 1 mM sodium citrate pH 6.4 (Gene Link, Cat No. 40–5014–05), and quantified by A260 measurement. The 3xFLAG-SMG6 reporter was capped using the Vaccinia Capping System (NEB, Cat No. M2080S) according to the manufacturer’s instructions with the modification that 1 U/μl RNase inhibitor (Vazyme, Cat. No. R301–03) was added to the reaction. The capped mRNA was isolated and quantified in the same way as after transcription. All in vitro transcribed mRNAs were aliquoted, snap-frozen, and stored at −80 °C.

In vitro translation

For in vitro translation, the lysates were used at a concentration of 1 × 108 cell equivalents/ml (stock = 2 × 108 cell equivalents/ml), unless otherwise stated, and supplemented with 1 U/μl RNase inhibitor (Vazyme, Cat. No. R301–03). The in vitro transcribed and capped mRNAs were incubated at 65 °C for 5 min and cooled on ice before addition. In vitro translation was performed at 37 °C for 1 hour, unless otherwise stated, and samples were afterward placed on ice. To inhibit translation as a negative control, 0.1 mM cycloheximide (CHX) was added to selected samples.

RRL in vitro translation reactions were carried out according to the manufacturer’s guidelines (Promega, Cat.No. L4960) for 60 min at 30 °C. For the comparison with RRL, the HEK FITR and HeLa S3 in vitro translation reactions contained 70% lysate (=1.4 ∗108 cell equivalents/ml f.c.). For the evaluation of the cap-dependence, in vitro translation reactions were supplemented with 0 to 1 mM of the free cap analog m7G(5′)ppp(5′)G (Ambion Cat. No. AM8050) and in vitro translation was performed at 33 °C for 1 hour.

Luciferase assay

Luciferase assays were performed using the Renilla-Glo system (Promega, Cat No. E2720). In vitro translation reactions were combined with 1x Renilla-Glo substrate in Renilla-Glo buffer in a 1:2 ratio, transferred to in a white-bottom 96-well plate (Greiner, Cat. No. 655073 or Corning, Ref 3917) and incubated at room temperature for 10 min. The luminescence was measured three times using the TECAN infinite M1000 Pro plate reader or Promega GloMax Explorer Microplate Reader GM3500 according to the manufacturer’s guidelines.

For the assessment of the luminescence readout of RRL translation reactions as shown in Figure S2E, the HeLa S3 and RRL reactions were diluted 1:1 with either HeLa S3 lysate or RRL (without reporter mRNA or other supplements).

Immunoblot analysis

All samples for Western blot analysis were diluted in 1.5x LDS loading buffer (Invitrogen, Cat No. NP0008) containing 50 mM DTT. The samples of 3xFLAG-RLuc and 3xFLAG-HBB were run on mPAGE 4 to 20% Bis-Tris, 15-well, mini gels (Millipore, mPAGE, 15-well, Cat No. MP42G15) (Fig. 2, A and D) or Criterion XT 4 to 12% Bis-Tris, 12 + 2, midi gels (Bio-Rad, Cat No. 3450123) (Figs. 3 and 4). The SMG6-3xFLAG samples were run on NuPAGE 3 to 8% Tris-Acetate, 10-well, mini gels (Invitrogen, Cat No. EA0378BOX) (Fig. 2E). MOPS, MES, and Tris-Acetate buffer were used for 3xFLAG-RLuc, 3xFLAG-HBB, and SMG6-3xFLAG translation reactions, respectively. Proteins were transferred on nitrocellulose membranes (Bio-Rad Cat No. 1704158 (mini) and Cat No. 1704159 (midi)) using the Trans-Blot Turbo Transfer system (Bio-Rad). Subsequently, the membranes were blocked with 5% milk in TBS containing 0.1% tween (TBS-t) and incubated overnight at 4 °C with the primary antibodies: Vinculin (Santa Cruz Biotechnology, Cat No. sc-73614, 1:500) and FLAG M2 (Sigma-Aldrich, Cat No. F3165, 1:2′000). The membranes were washed twice with TBS-t for 10 min and incubated for 1 h at room temperature with the IR-Dye-conjugated secondary antibodies: IRDye 680LT Donkey anti-Mouse IgG (1:10′000) and IRDye 800CW Goat anti-Mouse IgG2a-specific (1:10′000). Subsequently, the membranes were scanned using the Odyssey Infrared Imaging System 9120 (LiCor).

RNA extraction

RNA extraction for RT-qPCR analysis was carried out using the Maxwell RSC Instrument (Promega, Cat# AS4500) and the Maxwell RSC simplyRNA Cells Kit (Promega, Cat# AS1390), following the manufacturer’s protocol. RNA concentration after extraction was determined by NanoDrop 2000 spectrophotometer (Thermo Fisher Scientific) measurement.

RT-qPCR

For the RT-qPCR analysis, reverse transcription was conducted using 13.3 ng/μl RNA, 6 ng/μl random hexamers, 1x AffinityScript RT buffer (Agilent), 6.7 mM DTT, 0.27 mM dNTP mix (each), 0.27 u/μl Murine RNase inhibitor (Vazyme, Cat# R301–03) and 1.3% (v/v) AffinityScript Multiple Temperature Reverse Transcriptase (Agilent, Cat# 600109). The RNA and random hexamers were incubated at 65 °C for 5 min and were then left at room temperature for 10 min for primer annealing before the remaining components were added. Reverse transcription was performed at 50 °C for followed by an incubation at 75 °C for 15 min to inactivate the enzyme. The resulting cDNA was diluted with water to a final concentration of 8 ng/μl.

To quantify the cDNA levels, qPCR reactions were conducted containing 1x Brilliant III Ultra-Fast SYBR Green qPCR mix (Agilent, Cat# 600883), 1.6 ng/μl cDNA, and 0.5 μM of each primer (HBB-for: 5′ CACAACTGTGTTCACTAGCAACC 3′; HBB-rev: 5′ GGCCTCACCACCAACTTCATC 3′; GAPDH-for: 5′ GAGTCAACGGATTTGGTCG 3′; GAPDH-rev: 5′ GAGGTCAATGAAGGGGTCAT 3′) in 15 μl reactions, dispensed using the Myra Liquid Handling System (Bio Molecular Systems). qPCR was conducted using the Rotor-Gene Q (Qiagen) real-time system. Each experiment included an RT minus reaction (cDNA from a reverse transcription in which no reverse transcriptase was added) to control for DNA contamination. Threshold cycle values (CT-values) were manually determined using the Rotor-Gene Q–Pure Detection (Qiagen, version 2.3.1), and the relative mRNA levels were calculated using the comparative CT method.

Data availability

The authors confirm that the data supporting the findings of this study are available within the article and its supplementary materials. Original data and the plasmids generated from this study are available from the corresponding author upon reasonable request.

Supporting information

This article contains supporting information.

Conflict of interest

The authors declare that they have no conflicts of interest with the contents of this article.

Acknowledgments

We thank Sofia Nasif for critically reading the manuscript.

Author contributions

J. Z. and E. K. conceptualization; J. Z., N. Κ., N. S., P. T., and A. H. investigation; J. Z. methodology; J. Z., N. Κ., N. S., P. T., A. H., and O. M. writing–review & editing; O. M. and E. K. supervision; O. M. and E. K. funding acquisition.

Funding and additional information

This work was supported by the National Center of Competence in Research (NCCR) on RNA & Disease funded by the Swiss National Science Foundation (SNSF; grant 51NF40–141735), by SNSF grant 310030-204161 to O. M., by the canton of Bern (University intramural funding to O. M.). Grants awarded to EDK from the Swiss National Science Foundation (SNSF CRSK-3_220624), the Multidisciplinary Center of Infectious Diseases from the University of Bern (MCID), the Fondation Claude et Giuliana, the Forschungsstiftung of the University of Bern, and the Holcim Stiftung. Figure 4C was made using Biorender.

Reviewed by members of the JBC Editorial Board. Edited by Ronald Wek

Contributor Information

Oliver Mühlemann, Email: oliver.muehlemann@unibe.ch.

Evangelos D. Karousis, Email: evangelos.karousis@unibe.ch.

Supporting information

Supporting Information
mmc1.pdf (492.4KB, pdf)

References

  • 1.Swartz J. Developing cell-free biology for industrial applications. J. Ind. Microbiol. Biotechnol. 2006;33:476–485. doi: 10.1007/s10295-006-0127-y. [DOI] [PubMed] [Google Scholar]
  • 2.Carlson E.D., Gan R., Hodgman C.E., Jewett M.C. Cell-free protein synthesis: applications come of age. Biotechnol. Adv. 2012;30:1185–1194. doi: 10.1016/j.biotechadv.2011.09.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Ganesh R.B., Maerkl S.J. Biochemistry of aminoacyl tRNA synthetase and tRNAs and their engineering for cell-free and synthetic cell applications. Front. Bioeng. Biotechnol. 2022;10 doi: 10.3389/fbioe.2022.918659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Gao M., Wang D., Wilsch-Bräuninger M., Leng W., Schulte J., Morgner N., et al. Cell free expression in proteinosomes prepared from native protein-PNIPAAm conjugates. Macromolecular Biosci. 2024;24 doi: 10.1002/mabi.202300464. [DOI] [PubMed] [Google Scholar]
  • 5.Bains J.K., Qureshi N.S., Ceylan B., Wacker A., Schwalbe H. Cell-free transcription-translation system: a dual read-out assay to characterize riboswitch function. Nucleic. Acids. Res. 2023;51:e82. doi: 10.1093/nar/gkad574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Harris N.J., Pellowe G.A., Blackholly L.R., Gulaidi-Breen S., Findlay H.E., Booth P.J. Methods to study folding of alpha-helical membrane proteins in lipids. Open. Biol. 2022;12 doi: 10.1098/rsob.220054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Eto S., Matsumura R., Shimane Y., Fujimi M., Berhanu S., Kasama T., et al. Phospholipid synthesis inside phospholipid membrane vesicles. Commun. Biol. 2022;5:1–11. doi: 10.1038/s42003-022-03999-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Schoenmakers L.L.J., Yewdall N.A., Lu T., André A.A.M., Nelissen Frank.H.T., Spruijt E., et al. In vitro transcription–translation in an artificial biomolecular condensate. ACS. Synth. Biol. 2023;12:2004–2014. doi: 10.1021/acssynbio.3c00069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Robinson A.O., Lee J., Cameron A., Keating C.D., Adamala K.P. Cell-free expressed membraneless organelles inhibit translation in synthetic cells. ACS. Biomater. Sci. Eng. 2024;10:773–781. doi: 10.1021/acsbiomaterials.3c01052. [DOI] [PubMed] [Google Scholar]
  • 10.Pelham H.R.B., Jackson R.J. An efficient mRNA-dependent translation system from reticulocyte lysates. Eur. J. Biochem. 1976;67:247–256. doi: 10.1111/j.1432-1033.1976.tb10656.x. [DOI] [PubMed] [Google Scholar]
  • 11.Svitkin Y.V., Ovchinnikov L.P., Dreyfuss G., Sonenberg N. General RNA binding proteins render translation cap dependent. EMBO J. 1996;15:7147–7155. [PMC free article] [PubMed] [Google Scholar]
  • 12.Pisareva V.P., Muslimov I.A., Tcherepanov A., Pisarev A.V. Characterization of novel ribosome-associated endoribonuclease SLFN14 from rabbit reticulocytes. Biochemistry. 2015;54:3286–3301. doi: 10.1021/acs.biochem.5b00302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Karousis E.D., Gurzeler L.-A., Annibaldis G., Dreos R., Mühlemann O. Human NMD ensues independently of stable ribosome stalling. Nat. Commun. 2020;11:4134. doi: 10.1038/s41467-020-17974-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Garenne D., Haines M.C., Romantseva E.F., Freemont P., Strychalski E.A., Noireaux V. Cell-free gene expression. Nat. Rev. Methods. Primers. 2021;1:1–18. [Google Scholar]
  • 15.Bothe A., Ban N. A highly optimized human in vitro translation system. Cell. Rep. Methods. 2024;4 doi: 10.1016/j.crmeth.2024.100755. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Brödel A.K., Sonnabend A., Kubick S. Cell-free protein expression based on extracts from CHO cells. Biotechnol. Bioeng. 2014;111:25–36. doi: 10.1002/bit.25013. [DOI] [PubMed] [Google Scholar]
  • 17.Rakotondrafara A.M., Hentze M.W. An efficient factor-depleted mammalian in vitro translation system. Nat. Protoc. 2011;6:563–571. doi: 10.1038/nprot.2011.314. [DOI] [PubMed] [Google Scholar]
  • 18.O’Sullivan M.H., Fraser C.S. Monitoring RNA restructuring in a human cell-free extract reveals eIF4A-dependent and eIF4A-independent unwinding activity. J. Biol. Chem. 2023;299 doi: 10.1016/j.jbc.2023.104936. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Gurzeler L.-A., Ziegelmüller J., Mühlemann O., Karousis E.D. Production of human translation-competent lysates using dual centrifugation. RNA. Biol. 2022;19:78–88. doi: 10.1080/15476286.2021.2014695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Schubert K., Karousis E.D., Jomaa A., Scaiola A., Echeverria B., Gurzeler L.-A., et al. SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation. Nat. Struct. Mol. Biol. 2020;27:959–966. doi: 10.1038/s41594-020-0511-8. [DOI] [PubMed] [Google Scholar]
  • 21.Schubert K., Karousis E.D., Ban I., Lapointe C.P., Leibundgut M., Bäumlin E., et al. Universal features of Nsp1-mediated translational shutdown by coronaviruses. Mol. Cell. 2023;83:3546–3557.e8. doi: 10.1016/j.molcel.2023.09.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Baeumlin E., Andenmatten D., Luginbuehl J., Lalou A., Schwaller N., Karousis E.D. The impact of Coronavirus Nsp1 on host mRNA degradation is independent of its role in translation inhibition. Cell Reports. 2025;44 doi: 10.1016/j.celrep.2025.115488. [DOI] [PubMed] [Google Scholar]
  • 23.Meurs R., Matos M.D., Bothe A., Guex N., Weber T., Teleman A.A., et al. 2024. An in vitro assay of MCTS1-DENR-dependent re-initiation and ribosome profiling uncover the activity of MCTS2 and distinct function of eIF2D. [DOI] [Google Scholar]
  • 24.Yan G., Efferth T. Cell harvesting methods affect cellular integrity of adherent cells during apoptosis detection. Anticancer. Res. 2018;38:6669–6672. doi: 10.21873/anticanres.13034. [DOI] [PubMed] [Google Scholar]
  • 25.Eberle A.B., Lykke-Andersen S., Mühlemann O., Jensen T.H. SMG6 promotes endonucleolytic cleavage of nonsense mRNA in human cells. Nat. Struct. Mol. Biol. 2009;16:49–55. doi: 10.1038/nsmb.1530. [DOI] [PubMed] [Google Scholar]
  • 26.Huntzinger E., Kashima I., Fauser M., Saulière J., Izaurralde E. SMG6 is the catalytic endonuclease that cleaves mRNAs containing nonsense codons in metazoan. RNA. 2008;14:2609–2617. doi: 10.1261/rna.1386208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Cai A., Jankowska-Anyszka M., Centers A., Chlebicka L., Stepinski J., Stolarski R., et al. Quantitative assessment of mRNA cap analogues as inhibitors of in vitro translation. Biochemistry. 1999;38:8538–8547. doi: 10.1021/bi9830213. [DOI] [PubMed] [Google Scholar]
  • 28.Mikami S., Kobayashi T., Yokoyama S., Imataka H. A hybridoma-based in vitro translation system that efficiently synthesizes glycoproteins. J. Biotechnol. 2006;127:65–78. doi: 10.1016/j.jbiotec.2006.06.018. [DOI] [PubMed] [Google Scholar]
  • 29.Mikami S., Kobayashi T., Machida K., Masutani M., Yokoyama S., Imataka H. N-terminally truncated GADD34 proteins are convenient translation enhancers in a human cell-derived in vitro protein synthesis system. Biotechnol. Lett. 2010;32:897–902. doi: 10.1007/s10529-010-0251-7. [DOI] [PubMed] [Google Scholar]
  • 30.Kearse M.G., Green K.M., Krans A., Rodriguez C.M., Linsalata A.E., Goldstrohm A.C., et al. CGG repeat-associated non-AUG translation utilizes a cap-dependent scanning mechanism of initiation to produce toxic proteins. Mol. Cell. 2016;62:314–322. doi: 10.1016/j.molcel.2016.02.034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Karousis E.D., Schubert K., Ban N. Coronavirus takeover of host cell translation and intracellular antiviral response: a molecular perspective. EMBO J. 2024;43:151–167. doi: 10.1038/s44318-023-00019-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Stern-Ginossar N., Thompson S.R., Mathews M.B., Mohr I. Translational control in virus-infected cells. Cold. Spring. Harbor. Perspect. Biol. 2019;11 doi: 10.1101/cshperspect.a033001. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supporting Information
mmc1.pdf (492.4KB, pdf)

Data Availability Statement

The authors confirm that the data supporting the findings of this study are available within the article and its supplementary materials. Original data and the plasmids generated from this study are available from the corresponding author upon reasonable request.


Articles from The Journal of Biological Chemistry are provided here courtesy of American Society for Biochemistry and Molecular Biology

RESOURCES